Rockville, Md. The global electrosurgery devices market is set to reach roughly US$ 8 Bn by 2022 on above-average growth, according to Fact.MR, as surgery keeps shifting from traditional methods to minimally invasive techniques. An ageing population, projected by the WHO to reach about 2 billion people over 60 by 2050, is increasingly prone to conditions such as cardiac disease, gastrointestinal disorders and cancer, feeding demand for procedures that shorten hospital stays and recovery.
Radiofrequency devices dominate the product mix, hospitals account for most use, and North America leads by region. Patients favour electrosurgery for faster recovery, lower infection risk and ease of use across coagulation, cutting and thermofusion procedures.
Products, Settings and Applications
Radiofrequency devices hold more than half of revenue and post the highest CAGR, while ultrasonic devices stay sluggish. By setting, hospitals are the largest end user, specialized clinics grow fastest, and ambulatory surgical centers hold over a quarter of revenue as the second-largest segment. By application, gynecological surgery draws the largest revenue, gynecology and urology together grow at a 5.6% CAGR, and dermatology posts the fastest growth.
North America stays dominant, while Europe expands at a faster clip through the forecast period.
Minimally Invasive Shift Drives Demand
The market's momentum rests on how surgery is changing. High unmet need for minimally invasive procedures, combined with government investment in target-specific surgical devices, is pulling demand forward, and manufacturers are responding with tools that improve tissue vaporisation, multimodality use and combined coagulation and cutting.
Suppliers and Their Playbook
The field brings together large surgical device makers.
- Medtronic Plc, Bovie Medical Corporation, Johnson & Johnson Private Limited, Heal Force Bio-meditech Holdings Limited, Erbe Elektromedizin GmbH, B. Braun Melsungen AG, Boston Scientific Corporation, Stryker Corporation, Smith & Nephew, and AngioDynamics, Inc. are among the key players in the report.
Reading the Market for Decisions
For device makers, growth favours radiofrequency platforms and dermatology-focused tools. Investors get a market with a firm clinical tailwind. Procurement teams can plan around hospitals leading demand, radiofrequency devices carrying volume, and North America offering the largest opportunity while Europe grows faster through 2022.
About the Report
Fact.MR's study covers the global electrosurgery devices market for the 2017 to 2022 forecast period, with segmentation by product type, end user, application and region. It sizes each segment, maps the competitive field, and weighs the clinical forces shaping demand. Further detail is available in the electrosurgery devices market report.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. The firm is known for its syndicated research, custom research and consulting solutions, helping clients make decisions on demand, competition, investment, procurement and future growth.